novo nordisk glp-1 news India's weight-loss drug boom: talks about generics after patent expiry Novo Nordisk cuts GLP-1 prices
Description
Learn how to stop taking Ozempic safely
New research from Sweden has found that GLP-1 agonist drugs used to treat diabetes and obesity are unlikely to increase thyroid cancer risk, as some previous studies had suggested.
The GLP-1 gold rush is getting a lot less photogenic
Learn about their efficacy in controlling blood sugar and promoting wellness.
Compounded GLP has not been approved by the FDA for weight loss, but studies indicate potential benefits
Connect with Aetna nutritionists through Health Loft
